Adri Steenhoek

483 total citations
21 papers, 343 citations indexed

About

Adri Steenhoek is a scholar working on Economics and Econometrics, Pediatrics, Perinatology and Child Health and General Health Professions. According to data from OpenAlex, Adri Steenhoek has authored 21 papers receiving a total of 343 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Economics and Econometrics, 6 papers in Pediatrics, Perinatology and Child Health and 4 papers in General Health Professions. Recurrent topics in Adri Steenhoek's work include Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical studies and practices (6 papers) and Pharmaceutical Economics and Policy (5 papers). Adri Steenhoek is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (10 papers), Pharmaceutical studies and practices (6 papers) and Pharmaceutical Economics and Policy (5 papers). Adri Steenhoek collaborates with scholars based in Netherlands and Belgium. Adri Steenhoek's co-authors include R. Janknegt, Robert Janknegt, Tim A. Kanters, Leona Hakkaart‐van Roijen, Carin A. Uyl‐de Groot, Joris van de Klundert, M Franken, Marc Koopmanschap, Cornelis J. Stam and A Hagemeijer and has published in prestigious journals such as European Journal of Cancer, Clinical Pharmacology & Therapeutics and Drugs.

In The Last Decade

Adri Steenhoek

19 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adri Steenhoek Netherlands 10 131 82 62 59 58 21 343
Mê‐Linh Lê Canada 10 13 0.1× 40 0.5× 16 0.3× 37 0.6× 43 0.7× 38 395
Stefania Derni Italy 9 31 0.2× 85 1.0× 37 0.6× 181 3.1× 101 1.7× 14 642
Allen Haas United States 13 28 0.2× 12 0.1× 84 1.4× 6 0.1× 24 0.4× 41 419
Francesco Giorgianni Italy 13 91 0.7× 15 0.2× 45 0.7× 57 1.0× 2 0.0× 24 451
Jacqui Gath United Kingdom 7 19 0.1× 45 0.5× 7 0.1× 25 0.4× 11 0.2× 22 306
Jessamyn Conell‐Price United States 9 59 0.5× 37 0.5× 20 0.3× 43 0.7× 2 0.0× 13 457
Ariël M. Vondeling Netherlands 8 24 0.2× 10 0.1× 15 0.2× 27 0.5× 22 0.4× 10 275
Gregory M. Ouellet United States 14 80 0.6× 5 0.1× 36 0.6× 6 0.1× 23 0.4× 24 674
Anette Lampert Germany 11 60 0.5× 7 0.1× 28 0.5× 48 0.8× 7 0.1× 32 247
Eeva Reissell Finland 13 45 0.3× 44 0.5× 9 0.1× 14 0.2× 2 0.0× 29 597

Countries citing papers authored by Adri Steenhoek

Since Specialization
Citations

This map shows the geographic impact of Adri Steenhoek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adri Steenhoek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adri Steenhoek more than expected).

Fields of papers citing papers by Adri Steenhoek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adri Steenhoek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adri Steenhoek. The network helps show where Adri Steenhoek may publish in the future.

Co-authorship network of co-authors of Adri Steenhoek

This figure shows the co-authorship network connecting the top 25 collaborators of Adri Steenhoek. A scholar is included among the top collaborators of Adri Steenhoek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adri Steenhoek. Adri Steenhoek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Steenhoek, Adri, et al.. (2015). Productivity and quality of Dutch hospitals during system reform. Health Care Management Science. 19(3). 279–290. 39 indexed citations
2.
Kanters, Tim A., Adri Steenhoek, & Leona Hakkaart‐van Roijen. (2014). Budget Impact of Orphan Drugs In the Netherlands In The Period 2006-2012. Value in Health. 17(7). A525–A525. 2 indexed citations
3.
Groot, Carin A. Uyl‐de, et al.. (2014). The Drug Reimbursement Decision-Making System in Iran. Value in Health Regional Issues. 3. 174–181. 8 indexed citations
4.
Franken, M, Marc Koopmanschap, & Adri Steenhoek. (2014). Health economic evaluations in reimbursement decision making in the Netherlands: Time to take it seriously?. Zeitschrift für Evidenz Fortbildung und Qualität im Gesundheitswesen. 108(7). 383–389. 17 indexed citations
5.
Kanters, Tim A., Adri Steenhoek, & Leona Hakkaart‐van Roijen. (2014). Orphan drugs expenditure in the Netherlands in the period 2006–2012. Orphanet Journal of Rare Diseases. 9(1). 154–154. 24 indexed citations
6.
Sandmann, Frank, M Franken, Adri Steenhoek, & Marc Koopmanschap. (2013). Do reassessments reduce the uncertainty of decision making? Reviewing reimbursement reports and economic evaluations of three expensive drugs over time. Health Policy. 112(3). 285–296. 6 indexed citations
7.
Franken, M, Gepke O. Delwel, Wim Goettsch, et al.. (2012). Practical feasibility of outcomes research in oncology: Lessons learned in assessing drug use and cost-effectiveness in The Netherlands. European Journal of Cancer. 49(1). 8–16. 9 indexed citations
8.
Groot, Carin A. Uyl‐de, Saskia de Groot, & Adri Steenhoek. (2010). The economics of improved cancer survival rates: better outcomes, higher costs. Expert Review of Pharmacoeconomics & Outcomes Research. 10(3). 283–292. 8 indexed citations
9.
Steenhoek, Adri, Carin A. Uyl‐de Groot, & Frans Rutten. (2008). Uitkomstenonderzoek: hoogste tijd voor een definitie!. TSG - Tijdschrift voor gezondheidswetenschappen. 86(1). 18–21.
10.
Gool, Willem A. van, Cornelis J. Stam, Adri Steenhoek, & A Hagemeijer. (2006). [The practice guideline 'Diagnosis and pharmaceutical treatment of dementia'].. PubMed. 150(15). 839–43. 25 indexed citations
11.
Niezen, Maartje, Elly Stolk, Adri Steenhoek, & Carin A. Uyl‐de Groot. (2006). Inequalities in oncology care: Economic consequences of high cost drugs. European Journal of Cancer. 42(17). 2887–2892. 24 indexed citations
12.
Janknegt, Robert & Adri Steenhoek. (1997). The System of Objectified Judgement Analysis (SOJA). Drugs. 53(4). 550–562. 38 indexed citations
13.
Bet, Pierre M. & Adri Steenhoek. (1992). ACE-REMMERS. EEN PREPARAATKEUZE VOLGENS DE SOJA-METHODE. Data Archiving and Networked Services (DANS). 127(47). 1262–1271. 1 indexed citations
14.
Steenhoek, Adri. (1990). Prophylactic antibiotics and the hospital budget: controversy for patients and hospital financial strategies?. Pharmacy World & Science. 12(6). 300–302. 7 indexed citations
15.
Everdingen, J.J.E. van, Niek Klazinga, P.J. van den Broek, Adri Steenhoek, & R. P. Mouton. (1990). [Inventory and comparison of guidelines for antibiotic utilization in Dutch hospitals].. PubMed. 134(33). 1604–7. 2 indexed citations
16.
Steenhoek, Adri, et al.. (1988). Clinical pharmacokinetics of midazolam in intensive care patients, a wide interpatient variability?. Clinical Pharmacology & Therapeutics. 43(3). 263–269. 101 indexed citations
17.
Janknegt, R., et al.. (1988). Pharmacokinetics of methotrexate in continuous ambulatory peritoneal dialysis. Pharmacy World & Science. 10(2). 86–89. 11 indexed citations
18.
Steenhoek, Adri, et al.. (1984). Sustained-Release Theophylline Preparations. Respiration. 45(1). 1–15. 17 indexed citations
19.
Steenhoek, Adri. (1981). Geneesmiddelen via een infuus. Pharmacy World & Science. 3(1). 621–627.
20.
Paans, Anne M. J., Robert J. Nickles, Willem Vaalburg, et al.. (1978). A dual head anger camera system for the imaging of positron-emitting radionuclides. International Journal of Nuclear Medicine and Biology. 5(6). 266–271. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mê‐Linh Lê Breakdown of academic impact, for papers by Stefania Derni Breakdown of academic impact, for papers by Allen Haas Breakdown of academic impact, for papers by Francesco Giorgianni Breakdown of academic impact, for papers by Jacqui Gath Breakdown of academic impact, for papers by Jessamyn Conell‐Price Breakdown of academic impact, for papers by Ariël M. Vondeling Breakdown of academic impact, for papers by Gregory M. Ouellet Breakdown of academic impact, for papers by Anette Lampert Breakdown of academic impact, for papers by Eeva Reissell
Rankless by CCL
2026